From January 1, 2024 to March 31, 2024, the company has repurchased 1,267,900 shares, representing 0.09% for CNY 34.98 million. With this, the company has completed the repurchase of 1,488,200 shares, representing 0.11% for CNY 39.23 million under the buyback announced on September 21, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
30.39 CNY | -1.14% | -5.74% | -0.42% |
04-22 | CSPC Innovation Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04-19 | China's drugmakers can't sell mRNA shots but haven't quit yet | RE |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-0.42% | 5.89B | |
+13.74% | 8.18B | |
+5.29% | 7.53B | |
-6.67% | 3.7B | |
-10.75% | 3.57B | |
-8.21% | 1.26B | |
-29.10% | 1.08B | |
+14.92% | 991M | |
-12.46% | 894M | |
-17.68% | 794M |
- Stock Market
- Equities
- 300765 Stock
- News CSPC Innovation Pharmaceutical Co., Ltd.
- Tranche Update on CSPC Innovation Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on September 21, 2023.